Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
Top Cited Papers
- 1 May 2012
- journal article
- research article
- Published by Elsevier BV in The Journal of Pain
- Vol. 13 (5), 438-449
- https://doi.org/10.1016/j.jpain.2012.01.003
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Relationship between mood disturbance and sleep quality in oncology outpatients at the initiation of radiation therapyEuropean Journal of Oncology Nursing, 2010
- Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology ProgramJournal of Clinical Oncology, 2010
- Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study of the Efficacy, Safety, and Tolerability of THC:CBD Extract and THC Extract in Patients with Intractable Cancer-Related PainJournal of Pain and Symptom Management, 2009
- Cannabinoid–opioid interactions during neuropathic pain and analgesiaCurrent Opinion in Pharmacology, 2009
- Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trialPain, 2007
- The principles of cancer pain managementClinical Medicine, 2006
- Development and validation of the Patient Assessment of Constipation Quality of Life questionnaireScandinavian Journal of Gastroenterology, 2005
- The Epidemiology of Cancer PainCancer Investigation, 2005
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979